-
Corona Paez I., Canestro Marquez F., Pavon M.J.,"Los nuevos anticonceptivos
orales”. Formación médica continuada en A.P. 2001; 8:475-87
- Buil Rada C, Coll
Capdevila C, Lete Lasa I, Martínez San Andrés F. Manual de anticoncepción
hormonal oral. Zaragoza: Sociedad Española de Contracepción; 1.997.
p. 187-205.
- Third generation oral contraceptive. Caution is still justified
[Editorial]. BMJ 2000; 321:190-191.
- Grupo Daphne. III Encuesta Schering
sobre anticoncepción en
España. 2001. Disponible en: http://db.doyma.es/cgi-bin/wdbcgi.s/
doyma/press
- Imaz FJ, López F, Otero S. Interacciones de los anticonceptivos.
FMC 1999; 6: 42-48.
- Iyer V, Farquhar C, Jepson R. Oral contraceptive pills
for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; (2): CD000154.
- Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and
risk of venous thrombosis: metaanalysis. BMJ 2001; 323: 1-9.
- Oelkers W.
Drospirenone: a new progestogen with antimineralocorticoid activity, resembling
natural progesterone. Eur J Contracept Reprod Health Care 2000; 5 (Suppl 3): 17-24.
-
Stewart FH, Harper CC, Elertson CE, Grimes DA, Azuaya GF, Trussell J. Clinical
breast and pelvic examination requirements for hormonal contraception. JAMA 2001;
285: 2232-2239.
- Vandedbroucke JP, Rosing J, Bloemenkamp KWM, Middeldorp S,
Helmerhorst FM, Bouma BN, et al. Oral contraconceptives and the risk of venous
thrombosis. N Engl J Med 2001; 344:1527-35. |
